The SRT-100™ is an excellent treatment option for patients with the following conditions:
The SRT-100™ is comparable to surgery and is 97% effective in curing basal and squamous cell skin cancer.
The SRT-100™ is comparable to surgery and is 97% effective in curing basal and squamous cell skin cancer.
The SRT-100™ is very effective in treating keloids and boasts a cure rate of 90%.
Depending on the treatment protocol your physician chooses for your particular case, you may need several treatments per week for up to several weeks.
The SRT-100™ is a safe and proven technology that effectively treats non-melanoma skin cancers, keloid scarring, actinic keratosis and Kaposi’s sarcoma. It is utilized by dermatologists and radiation oncologists all over the world because it delivers good patient outcomes.
You should expect the same results as surgery, but with these additional benefits:
The SRT-100™ doesn’t harm surrounding or underlying healthy tissue while targeting cancer cells. The SRT-100™ provides excellent cosmetic outcomes and is a great alternative for patients with various co-morbidities.
No. The SRT-100™ is a non-invasive procedure. Since it does not require incisions, patients are not left with any scarring post-treatment.
Yes, the SRT-100™ has been cleared by the Federal Drug Administration for use on the entire body—making it especially effective in the treatment of non-melanoma skin cancer and keloid scars.
In cases where there are larger possible risks, you may be asked to agree in writing to the doctor’s plan for your care. This is part of informed consent. It recognizes your need to know about a procedure, surgery, or treatment, before you decide whether to have it.
It’s common to go through the informed consent process before starting cancer treatment. If you are getting more than one type of treatment, you will likely need separate informed consents for surgery, chemotherapy, and radiation.
After your first talk with your doctor, you may have only a general idea of the treatment plan. You’ll likely want to know more so that you can think about the ways this plan may affect your health and your life. In order to freely decide whether the risks are worth the benefits you expect to get from the treatment plan, you must understand the risks and drawbacks of the plan. Most people find that they need to get some questions answered before they can decide on a treatment plan that carries some risk for them.
Informed consent is a process that includes all of these steps:
If you have gone through these steps and decide to agree to the treatment or procedure, you are usually asked to sign a paper called a consent form. The completed and signed consent form is a legal document that lets your doctor go ahead with the treatment plan. The consent form names the procedure or treatment to be done. The rest of the form may be very general, stating only that you have been told about the risks of the treatment and other available options. Or it may be very detailed, outlining what the risks and other options are. Depending on how it’s presented, you may sign for one certain procedure or treatment, or you may give blanket approval for any treatments and procedures that the health provider decides are needed.
From the doctor’s viewpoint, informed consent means:
Sometimes health care workers refer to the consent form itself as an “informed consent.” This is not quite accurate. Informed consent is the process and actions that take place as you learn about and think about a treatment before you agree to it. Your signature on the form is taken to be evidence that this took place. If you decide that you do not want the procedure or treatment, you should not sign the consent form. In this case, you may be asked to sign an informed refusal form or a form that states you are choosing not to follow medical advice. Your signature on this form implies that you know the risks of refusing, so be sure that you understand these risks and know your other options before you sign.
The SRT-100™ is an excellent treatment option for patients with the following conditions:
The SRT-100™ is comparable to surgery and is 97% effective in curing basal and squamous cell skin cancer.
The SRT-100™ is very effective in treating keloids and boasts a cure rate of 90%.
The SRT-100™ is a compact, low-profile unit that has a space-saving 30” x 30” footprint. Medical-grade wheels and a standard wall socket plug-in make it easy to position the unit nearby so you can provide patients with safe, painless and effective treatment right in your office instead of referring them to another care provider.
Unlike more powerful radiation therapy devices, the SRT-100™ delivers a precise, calibrated low-dose. 100% of the dose is deposited at the surface and goes no deeper than 10mm. As a result, the SRT-100™ does not harm surrounding or underlying healthy tissue while targeting cancer cells or keloid scars. The SRT-100™ offers multiple energies to maximize the treatment results for various indications and lesions. Additionally, the SRT-100™ requires no consumables leading to substantial cost savings.
No, the SRT-100™ does not require consumables.
The SRT-100™ can be used to treat lesions on the arms, legs, back and trunk, but it is especially well suited for skin cancers of the head and neck regions—the fold in the nose, eyelids, lips, corners of the mouth, and the lining of the ear—areas that would otherwise lead to a less than desirable cosmetic outcome. SRT is also a great treatment option for patients who are considered high risk for surgical procedures.
